Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 244

1.

Successful treatment for various arrhythmias in an older patient treated with pilsicainide for paroxysmal supraventricular tachycardia.

Etoh R, Ishimatsu T, Kawano H, Tomichi Y, Arakawa S, Doi Y, Fukae S, Maemura K.

Geriatr Gerontol Int. 2018 Oct;18(10):1520-1521. doi: 10.1111/ggi.13520. No abstract available.

PMID:
30311445
2.

Development of monomorphic ventricular tachycardia in a patient with fever-induced Brugada syndrome.

Sato Y, Aizawa Y, Fujisawa T, Ito S, Katano K, Fuse N, Miyabe A, Osada K, Ishihara R, Tosaka A, Tamamura T, Mizumura T, Sugimura Y, Nakajima K, Katsumata Y, Nishiyama T, Kimura T, Furukawa Y, Takatsuki S, Kosaki K, Fukuda K.

J Arrhythm. 2018 Jun 4;34(4):465-468. doi: 10.1002/joa3.12068. eCollection 2018 Aug.

3.

Pilsicainide Poisoning: An Autopsy Case and Review of Literature.

Fukasawa M, Ninomiya K, Kawakami Y, Fuke C, Miyazaki T.

Am J Forensic Med Pathol. 2018 Dec;39(4):357-359. doi: 10.1097/PAF.0000000000000422.

PMID:
30028738
4.

Evaluation of the antinociceptive activities of several sodium channel blockers using veratrine test in mice.

Yoshizawa K, Arai N, Suzuki Y, Nakamura T, Takeuchi K, Sakamoto R, Masuda R.

Synapse. 2018 Jul 11. doi: 10.1002/syn.22056. [Epub ahead of print]

PMID:
29993143
5.

Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.

Ueoka A, Morita H, Watanabe A, Morimoto Y, Kawada S, Tachibana M, Miyamoto M, Nakagawa K, Nishii N, Ito H.

J Am Heart Assoc. 2018 May 10;7(10). pii: e008617. doi: 10.1161/JAHA.118.008617.

6.

Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes.

Kuroda Y, Yuasa S, Watanabe Y, Ito S, Egashira T, Seki T, Hattori T, Ohno S, Kodaira M, Suzuki T, Hashimoto H, Okata S, Tanaka A, Aizawa Y, Murata M, Aiba T, Makita N, Furukawa T, Shimizu W, Kodama I, Ogawa S, Kokubun N, Horigome H, Horie M, Kamiya K, Fukuda K.

Biochem Biophys Rep. 2017 Jan 11;9:245-256. doi: 10.1016/j.bbrep.2017.01.002. eCollection 2017 Mar.

7.

Paroxysmal atrial fibrillation recurrences and quality of life in symptomatic patients: A crossover study of flecainide and pilsicainide.

Shiga T, Yoshioka K, Watanabe E, Omori H, Yagi M, Okumura Y, Matsumoto N, Kusano K, Oshiro C, Ikeda T, Takahashi N, Komatsu T, Suzuki A, Suzuki T, Sato Y, Yamashita T; AF-QOL study investigators.

J Arrhythm. 2017 Aug;33(4):310-317. doi: 10.1016/j.joa.2017.03.005. Epub 2017 May 17.

8.

Inhibitory effects of local anesthetics on the proteasome and their biological actions.

Bahrudin U, Unno M, Nishio K, Kita A, Li P, Kato M, Inoue M, Tsujitani S, Murakami T, Sugiyama R, Saeki Y, Obara Y, Tanaka K, Yamaguchi H, Sakane I, Kawata Y, Itoh T, Ninomiya H, Hisatome I, Morimoto Y.

Sci Rep. 2017 Jul 11;7(1):5079. doi: 10.1038/s41598-017-04652-2.

9.

Molecular mechanisms underlying the pilsicainide-induced stabilization of hERG proteins in transfected mammalian cells.

Onohara T, Hisatome I, Kurata Y, Li P, Notsu T, Morikawa K, Otani N, Yoshida A, Iitsuka K, Kato M, Miake J, Ninomiya H, Higaki K, Shirayoshi Y, Nishihara T, Itoh T, Nakamura Y, Nishimura M.

J Arrhythm. 2017 Jun;33(3):226-233. doi: 10.1016/j.joa.2016.09.003. Epub 2016 Oct 19.

10.

Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.

Kakihara J, Takagi M, Hayashi Y, Tatsumi H, Doi A, Yoshiyama M.

Heart Vessels. 2017 Sep;32(9):1151-1159. doi: 10.1007/s00380-017-0973-8. Epub 2017 Mar 31.

PMID:
28364267
11.

Characterization of microminipigs as an in vivo experimental model for cardiac safety pharmacology.

Matsukura S, Nakamura Y, Cao X, Wada T, Izumi-Nakaseko H, Ando K, Yamazaki H, Sugiyama A.

J Pharmacol Sci. 2017 Feb;133(2):103-109. doi: 10.1016/j.jphs.2017.02.002. Epub 2017 Feb 11.

12.

Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation.

Aoki H, Nakamura Y, Ohno S, Makiyama T, Horie M.

J Arrhythm. 2017 Feb;33(1):35-39. doi: 10.1016/j.joa.2016.05.007. Epub 2016 Jul 2.

13.

Local Left Ventricular Epicardial J Waves and Late Potentials in Brugada Syndrome Patients with Inferolateral Early Repolarization Pattern.

Nagase S, Tanaka M, Morita H, Nakagawa K, Wada T, Murakami M, Nishii N, Nakamura K, Ito H, Ohe T, Kusano KF.

Front Physiol. 2017 Jan 26;8:14. doi: 10.3389/fphys.2017.00014. eCollection 2017.

14.

Assessment of drug-induced proarrhythmias due to pilsicainide in patients with atrial tachyarrhythmias.

Koike H, Fujino T, Koike M, Yao S, Shinohara M, Kitahara K, Kinoshita T, Yuzawa H, Suzuki T, Sato H, Fukunaga S, Kobayashi K, Ikeda T.

J Arrhythm. 2016 Dec;32(6):468-473. Epub 2016 May 26.

15.

Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.

Sasaoka S, Matsui T, Hane Y, Abe J, Ueda N, Motooka Y, Hatahira H, Fukuda A, Naganuma M, Hasegawa S, Kinosada Y, Nakamura M.

PLoS One. 2016 Oct 10;11(10):e0164309. doi: 10.1371/journal.pone.0164309. eCollection 2016.

16.

A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.

Turker I, Makiyama T, Vatta M, Itoh H, Ueyama T, Shimizu A, Ai T, Horie M.

PLoS One. 2016 Aug 25;11(8):e0161872. doi: 10.1371/journal.pone.0161872. eCollection 2016.

17.

Coved-type ST-elevation during ablation of ischemic ventricular tachycardia.

Hori Y, Nakahara S, Tsukada N, Nakagawa A, Hayashi A, Komatsu T, Kobayashi S, Sakai Y, Taguchi I.

J Arrhythm. 2015 Oct;31(5):316-7. doi: 10.1016/j.joa.2015.02.001. Epub 2015 Mar 23.

18.

Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome.

Yamasaki H, Tada H, Sekiguchi Y, Aonuma K.

Heart Vessels. 2016 Aug;31(8):1397-401. doi: 10.1007/s00380-015-0760-3. Epub 2015 Oct 28.

PMID:
26510553
19.

Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.

Aguilar M, Xiong F, Qi XY, Comtois P, Nattel S.

Circulation. 2015 Dec 8;132(23):2203-11. doi: 10.1161/CIRCULATIONAHA.115.018016. Epub 2015 Oct 23.

PMID:
26499964
20.

Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block.

Wada T, Nagase S, Morita H, Nakagawa K, Nishii N, Nakamura K, Kohno K, Ito H, Kusano KF, Ohe T.

Circ J. 2015;79(12):2568-75. doi: 10.1253/circj.CJ-15-0618. Epub 2015 Oct 8.

Supplemental Content

Loading ...
Support Center